Dr. Asanghanwa Alahkala Milca Nkiebifu

Faculty of Health Sciences

University of Bamenda, Cameroon

Email: masangha@yahoo.com

Qualifications

2014 Ph.D., Vrije Universiteit Brussel, Belgium

2008 M.Sc., Vrije Universiteit Brussel, Belgium

2004 B.Sc., University of Buea, Cameroon

Publications (Selected)

1. Prevalence of Diabetes mellitus II and Impaired Fasting Glycemia in Patients Diagnosed with Pulmonary Tuberculosis at the Bamenda Regional Hospital – Cameroon. Mary Chia Garba, Asanghanwa Milca, Agbor Esther Etengeneng, Lidi Loretta. American Scientific Journal for Engineering, Technology and Sciences ASRJETS. ISSN (Online) 2313 – 4402. http://asrjetsjournal.org/.
2. Profile and Antibiotic Susceptibility Pattern of Coliform Bacteria in Urinary Tract Infections Among Type 2 Diabetic Patients. Asanghanwa Milca A, Chia Ethylene A, Kamga Henri-L. African Journal of Integrated Health. Vol 10: No. 1 ; June 2020 Pages 20-23.
3. Electrolyte Imbalance in Type 2 Diabetes: a case study from the West Region of Cameroon. Jean Pierre Sayouba, Milca Asanghanwa, Abel Njouendou, Henri Kamga, Jules Assob. International Journal of Research in Medical Sciences. Vol 8, Issue 6, June 2020 Page 2022.
4. Sensibilite et Specificite de la presentation clinique pour la classification des patients ages de moins de 40ans nouvellement diagnostiques avec le diabete. A. Boli, E. Sobngwi, M. Dehayem, M. Asanghanwa et al. Diabetes and Metabolism 2016. March 42 (1): A71. DOI:1016/S1262-3636(16) 30264-6 CA-132.
5. Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to auntoantibody status and comparison with Belgian patients. Asanghanwa M, Gorus F, Weets I et al. Diab Res Clin Pract, 2014.
6. Validation of an enzyme-linked immunosorbent assay for C-peptide analysis in Cameroon. Asanghanwa M, van Genderen F, Verhaeghen K et al. Diab Res Clin Pract 2012 http://dx.doi.org/10.1016/j.diabres.2012.09.042.
7. Contribution of antibodies against IA-2β and ZnT8 to classification of diabetes diagnosed under 40 years of age. Vermeulen I, Weets I, Asanghanwa M, Ruige J, Van Gaal L, Mathieu C, Keymeulen B, Lampasona V, Wenslau JM, Hutton JC, Pipeleers DG, Gorus FK and the Belgian Diabetes Registry. Diabetes Care 2011. Aug 34 (8): 1760 – 1765.
8. An important minority of prediabetes first-degree relatives of type 1 diabetic patients derives from seroconvertion to persistent autoantibody positivity after 10 years of age. Vermeulen I, Weets I, Costa O, Asanghanwa M et al. Diabetologia 2011 Nov: DOI 10.1007/s00125-011-2376-1.
9. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. De Grijse J, Asanghanwa M, Nouthe B, Albrecher N, Goubert P, Vermeulen I, Van Der Meeren S, Decochez K, Weets I, Keymeulen B, Lampasona V, Wenslau J, Hutton JC, Pipeleers D, Gorus FK; Belgian Diabetes Registry. Diabetologia 2010. Mar 53 (3): 517 – 524.
10. Vaccination Coverage and the Risk of Hepatitis B Virus Infection amongst Medical and Paramedical Students Practicing at the Bamenda Regional Hospital in Cameroon Sub Saharan Africa. Milca A. Asanghanwa, Menji B. Nyuykighan, Odelia Kwende-Tanjong, Esther Agbor. IJCM, 2021, 211-223